Vivani Medical
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Vivani Medical generated cash of -$23,699,000, which is less than the previous year. Cash used in financing activities reached the amount of $133,000 last year. Net change in cash is therefore -$24,450,000.
Cash Flow
| 2014 | -17.09M | -25.94M | 43.80M |
|---|---|---|---|
| 2015 | -20.54M | 17.51M | 2.75M |
| 2016 | -25.07M | 4.88M | 20.45M |
| 2017 | -23.94M | 2.84M | 21.16M |
| 2018 | -29.81M | -163K | 26.60M |
| 2019 | -27.62M | -493K | 34.98M |
| 2020 | -7.61M | -150K | 9.18M |
| 2021 | -10.95M | -572K | 11.62M |
| 2022 | -18.78M | -338K | 63.39M |
| 2023 | -23.69M | -887K | 133K |
VANI Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 46.44M | 2.17M | 2.08M | 663K | 4.47M | 7.83M | 10.87M | 239K | 619K | 62.56K |
Operating activities | ||||||||||
Net income | -25.65M | -13.88M | -12.77M | -9.27M | -33.59M | -35.09M | -28.51M | -33.17M | -20.01M | -35.20M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 357K | 381K | 345K | 354K | 414K | 435K | 457K | 432K | 335K | 279.17K |
Stock-based compensation expense | 1.86M | 1.29M | 1.66M | 1.03M | 0 | 0 | 3.78M | 3.36M | 2.68M | 1.47M |
| Deferred income tax benefit | 1.86M | 1.29M | 1.66M | 1.03M | 0 | 0 | 3.78M | 3.36M | 2.68M | 1.47M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 461K | 48K | 1.22M | -1.41M | 955K | -793K | -239.00K |
Inventories | 0 | 0 | 0 | 529K | -347K | -1.17M | 3.86M | 10K | -2.48M | -3.37M |
Accounts payable | -602K | -1.94M | 13K | -18K | -213K | 554K | -419K | 446K | 197K | 198.77K |
Cash generated by operating activities | -23.69M | -18.78M | -10.95M | -7.61M | -27.62M | -29.81M | -23.94M | -25.07M | -20.54M | -17.09M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -25.38M |
Investments In Property Plant And Equipment | -887K | -338K | -572K | -150K | -493K | -163K | -265K | -490K | -762K | -560.35K |
Acquisitions Net | 0 | 0 | 0 | 398K | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -887K | -338K | -572K | -150K | -493K | -163K | 2.84M | 4.88M | 17.51M | -25.94M |
Financing activities | ||||||||||
Common Stock Issued | 133K | 16K | 11.62M | 8.55M | 34.98M | 25.93M | 21.16M | 0 | 2.88M | 43.29M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | -281K | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | -637K | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 133K | 63.39M | 11.62M | 9.18M | 34.98M | 26.60M | 21.16M | 20.45M | 2.75M | 43.80M |
Net Change In Cash | -24.45M | 44.26M | 98K | 1.41M | 6.85M | -3.36M | -3.03M | 300K | 15.34M | 556.84K |
Cash at end of period | 21.99M | 46.44M | 2.17M | 2.08M | 11.32M | 4.47M | 7.83M | 539K | 15.96M | 619.41K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |